Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002058052-25-000003
Filing Date
2025-02-28
Accepted
2025-02-27 20:53:24
Documents
1
Effectiveness Date
2025-02-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6342
  Complete submission text file 0002058052-25-000003.txt   7421
Mailing Address 95 MAIN ST. SUITE 9 LOS ALTOS CA 94022
Business Address 95 MAIN ST. SUITE 9 LOS ALTOS CA 94022 650-892-1942
Maxymune Therapeutics, Inc. (Filer) CIK: 0002058052 (see all company filings)

EIN.: 933707815 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-539494 | Film No.: 25682162